Answers are grounded in this paper and cite their sources.
One in 8 patients with ASCVD reports nonadherence to medications because of cost. The removal of financial barriers to accessing medications, particularly among vulnerable patient groups, may help improve adherence to essential therapy to reduce ASCVD morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Khera et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: